US Edition
Published • loading... • Updated
A waist of money?
Summary by westernindependent.com.au
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A waist of money?
On March 20, the patent on Semaglutide, the molecule used in GLP-1 drugs like Ozempic and Wegovy expired in India, allowing the release of cheaper alternatives. According to an article by the BBC, this could cause prices to drop rapidly and increase access for patients across India, and eventually globally. Wegovy is a GLP-1 that is commonly used for weight loss, Photo: Arianna Buonocore. Senior Lecturer at Curtin Law School, Dr Nikolas Koutras…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
